DescriptionCelgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health. We value our passion for patients, quest for innovation, spirit of independence and love of challenge. With a presence in more than 70 countries, and growing - we look for talented people to grow our business, advance our science and contribute to our unique culture.Bioengineer I Analytical Validation, CAR-TWarren, NJSummary:Design, perform, and interpret complex experiments in collaboration with process and analytical engineers focused on process characterization and validation, participate in process transfer for process updates, troubleshoot issues, and support GMP manufacturing activities. Guide engineers and strategic direction for cell culture experiments and communicate with external collaborators. \u00a0Responsibilities will include, but are not limited to, the following:Independently design and execute\/implement complex cellular process development and optimization studies requiring multiple engineers for executionOrganize and analyze data and contextualize to the literaturePrioritize scientific and organizational responsibilitiesMaintain proficiency in analytical skills, statistical analysis, and effective presentation of analysis Solve problems that arise, including those in larger teams and process transfersCollaborate with statisticians to design experiments and interpret dataPresent research findings to other groups and provide broader scientific guidanceDocument experimental results in peer-reviewed reportsTransfer processes between internal and external partnersLead supply of relevant product material for pre-clinical and analytical development studiesDefine\/maintain a safe work environment in accordance with policies\/procedures\/regulationsSkills\/Knowledge Required:B.S. in Biochemical, Chemical, or Biomedical Engineering or Biology related discipline with 5 - 8 years of relevant experience or M.S. with 4-9 years of relevant experienceCreativity to characterize processes for autologous cell-based therapiesExcellent organization skills and ability to handle multiple tasksHighly motivated, willingness to acquire new skills and ability to work without supervisionSstrong engineering or scientific knowledge appropriate for cellular process developmentAbility to assess risk and develop contingency plans for process risksMastery of mammalian cell culture and aseptic technique along with closed-system solutionsExperience working in a regulated environment and preparing regulatory documentsInterpersonal and leadership skills to work with teams in different functions and organizationsCelgene is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Celgene complies with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Celgene in the U.S.
Website : http://www.celgene.com
Celgene is a multinational biopharmaceutical company committed to improving the lives of patients worldwide. At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our mission as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. There are numerous clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocyte leukemia (CLL), non-Hodgkin's lymphoma (NHL), glioblastoma, and ovarian, pancreatic and prostate cancer.